SYLUMET FORTE is a pharmaceutical combination formulation that integrates three potent active ingredients: Lansoprazole, Tinidazole, and Clarithromycin. Specifically designed for the effective management of Helicobacter pylori infections and associated gastric conditions such as peptic ulcers and gastritis, this formulation works through a multi-pronged therapeutic approach. Lansoprazole, a proton pump inhibitor, reduces gastric acid secretion, thereby creating an unfavorable environment for bacteria. Tinidazole acts as a nitroimidazole antimicrobial, effectively targeting anaerobic bacteria and protozoa, while Clarithromycin, a macrolide antibiotic, inhibits bacterial protein synthesis to eradicate susceptible bacteria. This synergy ensures improved eradication rates and symptomatic relief in patients suffering from complex gastric infections. Ideal for pharmaceutical companies, hospitals, and clinics, SYLUMET FORTE is a valuable solution in the therapeutic regimen against H. pylori and related gastrointestinal ailments. The product is manufactured under strict quality control ensuring compliance with regulatory standards, making it a reliable option for B2B pharmaceutical procurement.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Lansoprazole, Tinidazole, Clarithromycin |
| Therapeutic Use | Treatment of Helicobacter pylori infection and related gastric conditions |
| Mechanism of Action | Proton pump inhibition, antimicrobial, and macrolide antibacterial activity |
| Formulation Strength | Combination dose strengths as per manufacturer specifications |
| Dosage Form | Oral tablets |
| Indications | Peptic ulcer, gastritis, H. pylori eradication therapy |
| Manufacturing Standards | Produced under GMP and quality regulatory compliances |
| Packaging | Blister packs or as per client requirements |
| Target Users | Hospitals, clinics, Pharmaceutical companies |
| Storage | Store in a cool, dry place away from direct sunlight |
| Attributes | Description |
|---|---|
| Lansoprazole Content | Typically 30 mg per tablet |
| Tinidazole Content | Typically 600 mg per tablet |
| Clarithromycin Content | Typically 500 mg per tablet |
| Tablet Type | Film-coated tablet |
| Shelf Life | Minimum 2 years from manufacture date |
| Packaging Details | Aluminum blister packing, 10 or 14 tablets per strip |
| Route of Administration | Oral |
| Storage Conditions | Store below 25°C, in a dry place |
| Compliance Standards | Manufactured according to Indian Pharmacopeia and regulatory guidelines |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
SYLUMET FORTE specifically targets Helicobacter pylori infections which are linked to peptic ulcers and gastritis.
The combination ensures acid suppression through Lansoprazole creating an optimal environment for antibiotics, while Tinidazole and Clarithromycin provide a potent antibacterial action targeting a broad spectrum of H. pylori bacteria.
Yes, SYLUMET FORTE is designed and manufactured for professional healthcare use, making it an appropriate choice for hospitals and clinics.
It should be stored in a cool, dry place below 25°C, protected from direct sunlight to maintain efficacy.
Yes, packaging such as blister packs in strips of 10 or 14 tablets can be customized as per client requirements in bulk procurement.
Combination of Lansoprazole, Tinidazole & Clarithromycin
